• Japanese
  • Korean
  • Chinese
Cover Image

Precancerous Condition Global Clinical Trials Review, H1, 2012

Abstract

Summary

GlobalData's clinical trial report, "Precancerous Condition Global Clinical Trials Review, H1, 2012" provides data on the Precancerous Condition clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Precancerous Condition. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Precancerous Condition. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Precancerous Condition Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Precancerous Condition , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Precancerous Condition
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials by Country
    • Top Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Countries Contributing to Clinical Trials in Middle East and Africa
    • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Precancerous Condition
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
    • Applied Genetic Technologies Corporation
    • Clinical Trial Overview of Applied Genetic Technologies Corporation
  • Clinical Trial Overview of Top Universities / Institutes / Hospitals
    • Mayo Clinic
    • Clinical Trial Overview of Mayo Clinic
    • British Columbia Cancer Agency
    • Clinical Trial Overview of British Columbia Cancer Agency
    • The University of Texas M. D. Anderson Cancer Center
    • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
    • Case Comprehensive Cancer Center
    • Clinical Trial Overview of Case Comprehensive Cancer Center
    • The University of Arizona
    • Clinical Trial Overview of The University of Arizona
    • Memorial Sloan Kettering Cancer Center
    • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
    • Barbara Ann Karmanos Cancer Institute
    • Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute
    • Northwestern University
    • Clinical Trial Overview of Northwestern University
    • Vanderbilt-Ingram Cancer Center
    • Clinical Trial Overview of Vanderbilt-Ingram Cancer Center
    • Sidney Kimmel Comprehensive Cancer Center
    • Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
    • Roswell Park Cancer Institute
    • Clinical Trial Overview of Roswell Park Cancer Institute
    • University of California, Irvine
    • Clinical Trial Overview of University of California, Irvine
    • Fred Hutchinson Cancer Research Center
    • Clinical Trial Overview of Fred Hutchinson Cancer Research Center
    • OHSU Knight Cancer Institute
    • Clinical Trial Overview of OHSU Knight Cancer Institute
    • City of Hope National Medical Center
    • Clinical Trial Overview of City of Hope National Medical Center
    • Massachusetts General Hospital
    • Clinical Trial Overview of Massachusetts General Hospital
    • University of Alabama at Birmingham
    • Clinical Trial Overview of University of Alabama at Birmingham
    • Fox Chase Cancer Center
    • Clinical Trial Overview of Fox Chase Cancer Center
    • University of Colorado
    • Clinical Trial Overview of University of Colorado
    • University of California, Los Angeles
    • Clinical Trial Overview of University of California, Los Angeles
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Precancerous Condition Therapeutics Market, Global, Clinical Trials by Zone, 2012*
  • Precancerous Condition Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
  • Precancerous Condition Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
  • Precancerous Condition Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
  • Precancerous Condition Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
  • Precancerous Condition Therapeutics Clinical Trials, North America, Top Countries, 2012*
  • Precancerous Condition Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012*
  • Precancerous Condition Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
  • Precancerous Condition Therapeutics Clinical Trials, BRIC Countries, 2012*
  • Precancerous Condition Therapeutics Clinical Trials, G7 Countries, 2012*
  • Precancerous Condition Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
  • Precancerous Condition Therapeutics Clinical Trials, E7 Countries, 2012*
  • Precancerous Condition Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
  • Precancerous Condition Therapeutics Market, Global, Clinical Trials by Phase, 2012*
  • Precancerous Condition Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
  • Precancerous Condition Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
  • Precancerous Condition Therapeutics Market, Global, Suspended Clinical Trials, 2012*
  • Precancerous Condition Therapeutics Market, Global, Terminated Clinical Trials, 2012*
  • Precancerous Condition Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
  • Precancerous Condition Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
  • Precancerous Condition Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by Applied Genetic Technologies Corporation, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by British Columbia Cancer Agency, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Arizona, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by OHSU Knight Cancer Institute, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2012*
  • Precancerous Condition Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012*

List of Figures

  • Precancerous Condition Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
  • Precancerous Condition Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
  • Precancerous Condition Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
  • Precancerous Condition Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012*
  • Precancerous Condition Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
  • Precancerous Condition Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
  • Precancerous Condition Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012*
  • Precancerous Condition Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
  • Precancerous Condition Therapeutics Clinical Trials, BRIC Countries (%), 2012*
  • Precancerous Condition Therapeutics Clinical Trials, G7 Countries (%), 2012*
  • Precancerous Condition Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
  • Precancerous Condition Therapeutics Clinical Trials, E7 Countries (%), 2012*
  • Precancerous Condition Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
  • Precancerous Condition Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
  • Precancerous Condition Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
  • Precancerous Condition Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
  • Precancerous Condition Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
  • Precancerous Condition Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
  • Precancerous Condition Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
  • GlobalData Methodology
Show More
Pricing
Get Notified
Email me when related reports are published